Artificial Tears Vision Loss Case Reports Published in March 2023 Medical...
JAMA Ophthalmology Articles Give Details About Serious Eye Infections Due to Use of EzriCare Eye Drops (Posted by Tom Lamb at Drug Injury Watch) Two recent JAMA Ophthalmology medical journal articles...
View ArticleProlia - Hypocalcemia Side Effect Safety Signal May Draw Regulatory Action by...
"Risk of severe hypocalcemia" in Patients on Dialysis Receiving Osteoporosis Drug Prolia (denosumab) (Posted by Tom Lamb at Drug Injury Watch) The FDA is in the process of evaluating the osteoporosis...
View ArticleTrulicity Recall Due to Dose Labeling Error Back in 2021 May Still be Drug...
Thousands of Trulicity Autoinjector Devices Labeled as 0.75 mg Might Contain 1.5 mg (i.e., a "double-dose") (Posted by Tom Lamb at Drug Injury Watch) A Trulicity recall back in August - September 2021...
View ArticleOzempic Gallbladder Injury Case Factors: When was the Ozempic Prescribed and...
March 2022 Ozempic Label Change About Risks of Gallbladder Disease is Just One Part of Legal Case Analysis (Posted by Tom Lamb at Drug Injury Watch) An Ozempic gallbladder disease warning was the...
View ArticleOzempic Side Effects: Gallbladder Diseases, Thyroid Cancer, And Suicidal...
Diabetes and Weight-Loss Drug Ozempic Getting Scrutiny From European Drug Safety Regulator EMA (Posted by Tom Lamb at Drug Injury Watch) The popular diabetes and weight-loss drug Ozempic (semaglutide)...
View ArticleEye Drug Syfovre Side Effects: Occlusive Retinal Vasculitis, Eye...
American Society of Retinal Specialists (ASRS) July 2023 Warning Letter About Adverse Events Reports Associated With Syfovre (Posted by Tom Lamb at Drug Injury Watch) On July 15, 2023, the American...
View ArticleSyfovre Retinal Vasculitis And Severe Intraocular Inflammation Cases Reported...
A July 2023 "Dear Doctor" Letter From Apellis Acknowledges This Developing Syfovre Safety Signal Situation (Posted by Tom Lamb at Drug Injury Watch) As we reported here recently, in mid-July 2023 the...
View ArticleTepezza Drug Label Change In July 2023 Adds Warning About Severe Hearing...
Earlier Versions of Tepezza Prescribing Information Document Did Not Include Hearing Loss Side Effects (Posted by Tom Lamb at Drug Injury Watch) Finally, in mid-July 2023, the Tepezza drug label now...
View ArticleSyfovre Adverse Reaction Cases: Updated Number of Patients With Retinal...
Additional Information from Apellis and the American Society of Retina Specialists About Ongoing Syfovre Safety Issues (Posted by Tom Lamb at Drug Injury Watch) In late July 2023, we learned more about...
View ArticleOzempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible,...
Severe Gastric Side Effects Include Stomach Paralysis, Gastroparesis, And Intestinal Blockages (Posted by Tom Lamb at Drug Injury Watch) Ozempic has been approved by the FDA as a treatment for diabetes...
View Article
